{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 0.06, "width": 1706, "height": 2286, "unit": "pixel", "lines": [{"boundingBox": [205, 202, 382, 207, 381, 240, 204, 235], "text": "4.6 Lipids", "words": [{"boundingBox": [207, 203, 255, 206, 255, 238, 207, 236], "text": "4.6"}, {"boundingBox": [285, 207, 381, 207, 381, 240, 285, 239], "text": "Lipids"}]}, {"boundingBox": [203, 282, 1494, 282, 1493, 318, 202, 317], "text": "In the CE/TMG treatment groups, significant increases from baseline values were seen", "words": [{"boundingBox": [205, 282, 233, 282, 234, 316, 205, 316], "text": "In"}, {"boundingBox": [240, 282, 291, 283, 291, 317, 240, 316], "text": "the"}, {"boundingBox": [297, 283, 427, 283, 427, 317, 297, 317], "text": "CE/TMG"}, {"boundingBox": [436, 283, 581, 284, 582, 318, 436, 318], "text": "treatment"}, {"boundingBox": [588, 284, 702, 284, 703, 319, 588, 318], "text": "groups,"}, {"boundingBox": [709, 284, 857, 285, 857, 319, 710, 319], "text": "significant"}, {"boundingBox": [863, 285, 1009, 285, 1009, 318, 864, 319], "text": "increases"}, {"boundingBox": [1015, 285, 1077, 285, 1078, 318, 1016, 318], "text": "from"}, {"boundingBox": [1092, 285, 1220, 285, 1221, 318, 1093, 318], "text": "baseline"}, {"boundingBox": [1227, 285, 1326, 284, 1327, 317, 1227, 318], "text": "values"}, {"boundingBox": [1332, 284, 1409, 284, 1410, 316, 1333, 317], "text": "were"}, {"boundingBox": [1416, 284, 1491, 284, 1492, 316, 1417, 316], "text": "seen"}]}, {"boundingBox": [206, 319, 1417, 320, 1416, 356, 205, 355], "text": "in HDL cholesterol (and subfractions HDL cholesterol and HDL cholesterol), and", "words": [{"boundingBox": [206, 321, 231, 321, 231, 353, 206, 353], "text": "in"}, {"boundingBox": [240, 321, 307, 321, 307, 354, 240, 353], "text": "HDL"}, {"boundingBox": [316, 321, 480, 322, 480, 355, 316, 354], "text": "cholesterol"}, {"boundingBox": [487, 322, 558, 322, 559, 356, 487, 355], "text": "(and"}, {"boundingBox": [565, 322, 744, 322, 745, 357, 565, 356], "text": "subfractions"}, {"boundingBox": [750, 322, 820, 322, 821, 357, 751, 357], "text": "HDL"}, {"boundingBox": [841, 322, 1004, 322, 1004, 357, 842, 357], "text": "cholesterol"}, {"boundingBox": [1010, 322, 1069, 322, 1070, 357, 1011, 357], "text": "and"}, {"boundingBox": [1075, 322, 1143, 322, 1144, 356, 1076, 357], "text": "HDL", "confidence": "Low"}, {"boundingBox": [1164, 322, 1350, 321, 1351, 355, 1165, 356], "text": "cholesterol),"}, {"boundingBox": [1356, 321, 1415, 320, 1416, 355, 1357, 355], "text": "and"}]}, {"boundingBox": [201, 357, 1494, 359, 1494, 396, 200, 394], "text": "decreases in LDL cholesterol that contributed to a decreased ratio of LDL cholesterol to", "words": [{"boundingBox": [208, 359, 359, 359, 359, 393, 208, 393], "text": "decreases"}, {"boundingBox": [366, 359, 395, 359, 395, 393, 366, 393], "text": "in"}, {"boundingBox": [402, 359, 467, 359, 468, 393, 402, 393], "text": "LDL"}, {"boundingBox": [474, 359, 636, 359, 637, 393, 474, 393], "text": "cholesterol"}, {"boundingBox": [643, 359, 702, 359, 702, 393, 643, 393], "text": "that"}, {"boundingBox": [709, 359, 875, 359, 876, 393, 709, 393], "text": "contributed"}, {"boundingBox": [882, 359, 914, 359, 914, 393, 882, 393], "text": "to"}, {"boundingBox": [920, 359, 943, 359, 943, 393, 921, 393], "text": "a"}, {"boundingBox": [952, 359, 1105, 359, 1106, 394, 952, 393], "text": "decreased"}, {"boundingBox": [1112, 359, 1182, 359, 1182, 394, 1112, 394], "text": "ratio"}, {"boundingBox": [1189, 359, 1218, 359, 1218, 395, 1189, 394], "text": "of"}, {"boundingBox": [1225, 359, 1290, 359, 1291, 395, 1225, 395], "text": "LDL"}, {"boundingBox": [1297, 359, 1459, 360, 1460, 396, 1297, 395], "text": "cholesterol"}, {"boundingBox": [1466, 360, 1493, 360, 1493, 396, 1466, 396], "text": "to"}]}, {"boundingBox": [202, 395, 1494, 397, 1494, 434, 201, 432], "text": "HDL cholesterol. Mean increases were seen in VLDL cholesterol and in triglycerides. In", "words": [{"boundingBox": [205, 396, 274, 397, 273, 432, 204, 432], "text": "HDL"}, {"boundingBox": [281, 397, 453, 399, 452, 433, 280, 433], "text": "cholesterol."}, {"boundingBox": [460, 399, 545, 399, 545, 433, 459, 433], "text": "Mean"}, {"boundingBox": [552, 400, 697, 400, 696, 433, 552, 433], "text": "increases"}, {"boundingBox": [704, 400, 782, 400, 781, 433, 703, 433], "text": "were"}, {"boundingBox": [789, 400, 860, 400, 859, 433, 788, 433], "text": "seen"}, {"boundingBox": [867, 400, 897, 400, 897, 433, 866, 433], "text": "in"}, {"boundingBox": [904, 400, 990, 400, 989, 434, 904, 433], "text": "VLDL"}, {"boundingBox": [997, 400, 1160, 400, 1159, 434, 996, 434], "text": "cholesterol"}, {"boundingBox": [1167, 400, 1223, 400, 1223, 434, 1167, 434], "text": "and"}, {"boundingBox": [1231, 399, 1261, 399, 1261, 434, 1230, 434], "text": "in"}, {"boundingBox": [1268, 399, 1455, 398, 1455, 434, 1268, 434], "text": "triglycerides."}, {"boundingBox": [1462, 398, 1493, 397, 1493, 434, 1462, 434], "text": "In"}]}, {"boundingBox": [200, 437, 1472, 438, 1471, 473, 199, 472], "text": "a comparison between the TMG cc and the HOPE study lipid changes at cycle 13, the", "words": [{"boundingBox": [206, 439, 226, 439, 224, 470, 204, 470], "text": "a"}, {"boundingBox": [234, 439, 408, 439, 406, 471, 233, 470], "text": "comparison"}, {"boundingBox": [414, 439, 542, 439, 540, 472, 412, 471], "text": "between"}, {"boundingBox": [550, 439, 599, 439, 597, 472, 548, 472], "text": "the"}, {"boundingBox": [611, 439, 680, 439, 678, 473, 609, 472], "text": "TMG"}, {"boundingBox": [691, 439, 727, 439, 725, 473, 689, 473], "text": "cc"}, {"boundingBox": [733, 439, 790, 439, 788, 473, 731, 473], "text": "and"}, {"boundingBox": [797, 439, 845, 439, 843, 473, 795, 473], "text": "the"}, {"boundingBox": [852, 439, 945, 439, 943, 473, 849, 473], "text": "HOPE"}, {"boundingBox": [957, 439, 1039, 439, 1037, 473, 955, 473], "text": "study"}, {"boundingBox": [1045, 439, 1108, 439, 1106, 473, 1043, 473], "text": "lipid"}, {"boundingBox": [1114, 438, 1247, 438, 1245, 473, 1112, 473], "text": "changes"}, {"boundingBox": [1253, 438, 1283, 438, 1281, 473, 1251, 473], "text": "at"}, {"boundingBox": [1289, 438, 1367, 438, 1365, 473, 1287, 473], "text": "cycle"}, {"boundingBox": [1377, 438, 1424, 438, 1422, 473, 1375, 473], "text": "13,"}, {"boundingBox": [1430, 438, 1473, 438, 1471, 473, 1428, 473], "text": "the"}]}, {"boundingBox": [205, 473, 1470, 475, 1469, 512, 204, 510], "text": "HDL-cholesterol changes were similar. Premarin/TMG doses had a very similar effect", "words": [{"boundingBox": [205, 474, 447, 475, 448, 511, 206, 511], "text": "HDL-cholesterol"}, {"boundingBox": [455, 475, 581, 475, 581, 511, 455, 511], "text": "changes"}, {"boundingBox": [588, 475, 664, 475, 664, 511, 588, 511], "text": "were"}, {"boundingBox": [671, 475, 778, 475, 778, 512, 671, 511], "text": "similar."}, {"boundingBox": [785, 475, 1004, 475, 1003, 512, 785, 512], "text": "Premarin/TMG"}, {"boundingBox": [1018, 475, 1103, 475, 1103, 512, 1017, 512], "text": "doses"}, {"boundingBox": [1111, 475, 1170, 475, 1169, 512, 1110, 512], "text": "had"}, {"boundingBox": [1177, 475, 1199, 475, 1198, 512, 1176, 512], "text": "a"}, {"boundingBox": [1206, 475, 1272, 475, 1271, 512, 1205, 512], "text": "very"}, {"boundingBox": [1279, 475, 1377, 475, 1376, 512, 1278, 512], "text": "similar"}, {"boundingBox": [1384, 475, 1470, 475, 1468, 513, 1383, 512], "text": "effect"}]}, {"boundingBox": [206, 510, 903, 513, 902, 555, 205, 551], "text": "on lipids as did Premarin 0.625mg/MPA 2.5mg.", "words": [{"boundingBox": [206, 515, 242, 514, 242, 549, 206, 549], "text": "on"}, {"boundingBox": [249, 514, 329, 514, 328, 549, 248, 549], "text": "lipids"}, {"boundingBox": [336, 514, 379, 513, 377, 549, 335, 549], "text": "as"}, {"boundingBox": [388, 513, 428, 513, 426, 549, 386, 549], "text": "did"}, {"boundingBox": [435, 513, 573, 513, 571, 550, 433, 549], "text": "Premarin"}, {"boundingBox": [580, 513, 792, 514, 789, 553, 578, 550], "text": "0.625mg/MPA"}, {"boundingBox": [801, 514, 902, 515, 898, 555, 798, 553], "text": "2.5mg."}]}, {"boundingBox": [206, 586, 698, 588, 697, 627, 205, 624], "text": "4.7 Carbohydrate Metabolism", "words": [{"boundingBox": [206, 586, 258, 587, 257, 625, 206, 624], "text": "4.7"}, {"boundingBox": [285, 587, 504, 589, 504, 627, 284, 625], "text": "Carbohydrate"}, {"boundingBox": [511, 589, 690, 590, 691, 624, 511, 627], "text": "Metabolism"}]}, {"boundingBox": [206, 666, 1443, 668, 1442, 704, 205, 703], "text": "Because of the preclinical finding of hyperglycemia in monkeys, there was particular", "words": [{"boundingBox": [207, 667, 338, 668, 337, 702, 206, 701], "text": "Because"}, {"boundingBox": [345, 668, 373, 668, 373, 703, 344, 703], "text": "of"}, {"boundingBox": [380, 668, 429, 668, 429, 703, 380, 703], "text": "the"}, {"boundingBox": [436, 668, 587, 669, 587, 704, 435, 703], "text": "preclinical"}, {"boundingBox": [594, 669, 694, 669, 694, 704, 593, 704], "text": "finding"}, {"boundingBox": [701, 669, 732, 670, 731, 704, 700, 704], "text": "of"}, {"boundingBox": [739, 670, 952, 670, 952, 704, 738, 704], "text": "hyperglycemia"}, {"boundingBox": [959, 670, 990, 670, 990, 704, 959, 704], "text": "in"}, {"boundingBox": [997, 670, 1142, 670, 1141, 703, 996, 704], "text": "monkeys,"}, {"boundingBox": [1148, 670, 1228, 670, 1228, 703, 1148, 703], "text": "there"}, {"boundingBox": [1235, 670, 1297, 670, 1297, 702, 1235, 703], "text": "was"}, {"boundingBox": [1304, 670, 1442, 670, 1442, 701, 1304, 702], "text": "particular"}]}, {"boundingBox": [205, 705, 1414, 704, 1415, 740, 206, 740], "text": "attention paid in the Premarin/TMG clinical trials to the monitoring of carbohydrate", "words": [{"boundingBox": [207, 707, 334, 706, 333, 741, 206, 741], "text": "attention"}, {"boundingBox": [341, 706, 405, 706, 404, 741, 340, 741], "text": "paid"}, {"boundingBox": [412, 706, 443, 706, 442, 741, 411, 741], "text": "in"}, {"boundingBox": [450, 706, 499, 706, 498, 741, 449, 741], "text": "the"}, {"boundingBox": [506, 706, 722, 705, 721, 741, 505, 741], "text": "Premarin/TMG"}, {"boundingBox": [735, 705, 835, 705, 834, 741, 734, 741], "text": "clinical"}, {"boundingBox": [842, 705, 915, 705, 915, 741, 841, 741], "text": "trials"}, {"boundingBox": [922, 705, 951, 705, 950, 741, 921, 741], "text": "to"}, {"boundingBox": [958, 705, 1006, 705, 1006, 741, 957, 741], "text": "the"}, {"boundingBox": [1013, 705, 1173, 706, 1173, 741, 1013, 741], "text": "monitoring"}, {"boundingBox": [1180, 706, 1211, 706, 1211, 740, 1180, 741], "text": "of"}, {"boundingBox": [1218, 706, 1414, 707, 1414, 740, 1218, 740], "text": "carbohydrate"}]}, {"boundingBox": [204, 744, 1476, 743, 1477, 780, 205, 781], "text": "metabolism in all subjects. Overall, there were no clinically important effects of any of", "words": [{"boundingBox": [206, 744, 370, 744, 370, 780, 205, 779], "text": "metabolism"}, {"boundingBox": [383, 744, 413, 744, 413, 780, 383, 780], "text": "in"}, {"boundingBox": [420, 744, 456, 744, 456, 781, 420, 780], "text": "all"}, {"boundingBox": [463, 744, 607, 744, 607, 781, 463, 781], "text": "subjects."}, {"boundingBox": [613, 744, 730, 744, 730, 781, 614, 781], "text": "Overall,"}, {"boundingBox": [736, 744, 814, 744, 815, 781, 737, 781], "text": "there"}, {"boundingBox": [821, 744, 893, 744, 895, 781, 822, 781], "text": "were"}, {"boundingBox": [900, 744, 941, 744, 943, 781, 901, 781], "text": "no"}, {"boundingBox": [948, 744, 1073, 744, 1075, 781, 949, 781], "text": "clinically"}, {"boundingBox": [1080, 744, 1226, 744, 1228, 780, 1082, 781], "text": "important"}, {"boundingBox": [1233, 744, 1333, 744, 1335, 779, 1235, 780], "text": "effects"}, {"boundingBox": [1340, 744, 1370, 744, 1372, 779, 1342, 779], "text": "of"}, {"boundingBox": [1376, 744, 1433, 744, 1436, 778, 1379, 779], "text": "any"}, {"boundingBox": [1440, 744, 1474, 744, 1477, 778, 1442, 778], "text": "of"}]}, {"boundingBox": [202, 782, 1492, 783, 1491, 818, 201, 817], "text": "the treatments on glucose metabolism as assessed by fasting glucose and insulin, oral", "words": [{"boundingBox": [204, 784, 253, 784, 253, 816, 204, 816], "text": "the"}, {"boundingBox": [260, 784, 421, 784, 420, 817, 259, 816], "text": "treatments"}, {"boundingBox": [427, 784, 465, 784, 465, 818, 427, 817], "text": "on"}, {"boundingBox": [474, 784, 590, 784, 590, 818, 474, 818], "text": "glucose"}, {"boundingBox": [597, 784, 762, 784, 762, 819, 597, 818], "text": "metabolism"}, {"boundingBox": [779, 784, 817, 784, 817, 819, 779, 819], "text": "as"}, {"boundingBox": [823, 784, 963, 784, 964, 819, 824, 819], "text": "assessed"}, {"boundingBox": [970, 784, 1010, 784, 1011, 819, 970, 819], "text": "by"}, {"boundingBox": [1016, 784, 1118, 783, 1119, 819, 1017, 819], "text": "fasting"}, {"boundingBox": [1124, 783, 1243, 783, 1244, 818, 1125, 819], "text": "glucose"}, {"boundingBox": [1249, 783, 1306, 783, 1308, 818, 1250, 818], "text": "and"}, {"boundingBox": [1313, 783, 1421, 783, 1422, 818, 1314, 818], "text": "insulin,"}, {"boundingBox": [1427, 783, 1489, 783, 1490, 818, 1429, 818], "text": "oral"}]}, {"boundingBox": [201, 821, 1448, 822, 1447, 857, 201, 857], "text": "glucose tolerance test, hemoglobin Ac, and monthly home urine glucose monitoring.", "words": [{"boundingBox": [204, 824, 321, 823, 320, 857, 204, 857], "text": "glucose"}, {"boundingBox": [327, 823, 467, 823, 466, 857, 326, 857], "text": "tolerance"}, {"boundingBox": [474, 822, 540, 822, 540, 857, 473, 857], "text": "test,"}, {"boundingBox": [547, 822, 724, 822, 723, 856, 546, 857], "text": "hemoglobin"}, {"boundingBox": [730, 822, 788, 822, 787, 856, 729, 856], "text": "Ac,", "confidence": "Low"}, {"boundingBox": [795, 822, 851, 822, 850, 856, 794, 856], "text": "and"}, {"boundingBox": [857, 822, 978, 822, 977, 856, 856, 856], "text": "monthly"}, {"boundingBox": [984, 822, 1071, 822, 1070, 856, 983, 856], "text": "home"}, {"boundingBox": [1077, 822, 1157, 822, 1156, 857, 1076, 856], "text": "urine"}, {"boundingBox": [1163, 823, 1280, 823, 1279, 857, 1162, 857], "text": "glucose"}, {"boundingBox": [1286, 823, 1448, 825, 1447, 857, 1285, 857], "text": "monitoring."}]}, {"boundingBox": [204, 859, 1327, 860, 1326, 897, 203, 896], "text": "The small changes in fasting glucose and insulin are expected with hormone", "words": [{"boundingBox": [208, 860, 264, 860, 265, 896, 209, 895], "text": "The"}, {"boundingBox": [271, 860, 350, 860, 351, 896, 272, 896], "text": "small"}, {"boundingBox": [357, 860, 485, 860, 486, 897, 358, 896], "text": "changes"}, {"boundingBox": [492, 860, 522, 860, 523, 897, 493, 897], "text": "in"}, {"boundingBox": [529, 861, 632, 861, 632, 897, 530, 897], "text": "fasting"}, {"boundingBox": [639, 861, 755, 861, 755, 898, 639, 897], "text": "glucose"}, {"boundingBox": [762, 861, 818, 861, 818, 897, 762, 898], "text": "and"}, {"boundingBox": [825, 861, 922, 861, 922, 897, 825, 897], "text": "insulin"}, {"boundingBox": [929, 861, 980, 862, 980, 897, 929, 897], "text": "are"}, {"boundingBox": [987, 862, 1125, 862, 1124, 896, 987, 897], "text": "expected"}, {"boundingBox": [1132, 862, 1194, 862, 1194, 896, 1131, 896], "text": "with"}, {"boundingBox": [1201, 862, 1327, 862, 1326, 894, 1201, 896], "text": "hormone"}]}, {"boundingBox": [203, 898, 518, 901, 518, 936, 202, 933], "text": "replacement therapy.", "words": [{"boundingBox": [203, 901, 393, 901, 393, 934, 203, 934], "text": "replacement"}, {"boundingBox": [399, 901, 518, 903, 519, 937, 399, 934], "text": "therapy."}]}, {"boundingBox": [208, 972, 1498, 974, 1497, 1011, 207, 1009], "text": "These data were part of a submission to the FDA on 21 Feb 02 that addressed the FDA", "words": [{"boundingBox": [208, 973, 303, 973, 303, 1010, 208, 1010], "text": "These"}, {"boundingBox": [310, 973, 374, 973, 373, 1009, 310, 1010], "text": "data"}, {"boundingBox": [381, 973, 454, 974, 453, 1009, 380, 1009], "text": "were"}, {"boundingBox": [461, 974, 522, 974, 521, 1009, 460, 1009], "text": "part"}, {"boundingBox": [529, 974, 561, 974, 560, 1009, 529, 1009], "text": "of"}, {"boundingBox": [568, 974, 587, 974, 587, 1009, 567, 1009], "text": "a"}, {"boundingBox": [595, 974, 762, 974, 762, 1009, 594, 1009], "text": "submission"}, {"boundingBox": [770, 974, 799, 974, 798, 1009, 769, 1009], "text": "to"}, {"boundingBox": [806, 974, 855, 974, 854, 1009, 805, 1009], "text": "the"}, {"boundingBox": [862, 974, 930, 974, 929, 1009, 861, 1009], "text": "FDA"}, {"boundingBox": [937, 974, 979, 974, 978, 1009, 937, 1009], "text": "on"}, {"boundingBox": [986, 974, 1025, 974, 1024, 1009, 985, 1009], "text": "21"}, {"boundingBox": [1032, 974, 1091, 974, 1090, 1009, 1031, 1009], "text": "Feb"}, {"boundingBox": [1098, 974, 1137, 974, 1136, 1009, 1097, 1009], "text": "02"}, {"boundingBox": [1144, 974, 1205, 974, 1204, 1010, 1143, 1009], "text": "that"}, {"boundingBox": [1212, 974, 1368, 974, 1367, 1011, 1211, 1010], "text": "addressed"}, {"boundingBox": [1375, 974, 1424, 974, 1423, 1011, 1374, 1011], "text": "the"}, {"boundingBox": [1431, 974, 1496, 974, 1496, 1011, 1430, 1011], "text": "FDA"}]}, {"boundingBox": [202, 1013, 1495, 1014, 1494, 1050, 201, 1049], "text": "concerns about hyperglycemia. The submission was reviewed by the Executive Safety", "words": [{"boundingBox": [205, 1014, 342, 1014, 342, 1049, 204, 1049], "text": "concerns"}, {"boundingBox": [349, 1014, 434, 1014, 434, 1049, 349, 1049], "text": "about"}, {"boundingBox": [441, 1014, 679, 1015, 679, 1050, 440, 1049], "text": "hyperglycemia."}, {"boundingBox": [689, 1015, 746, 1015, 746, 1050, 688, 1050], "text": "The"}, {"boundingBox": [753, 1015, 920, 1015, 920, 1050, 753, 1050], "text": "submission"}, {"boundingBox": [927, 1015, 987, 1015, 987, 1050, 927, 1050], "text": "was"}, {"boundingBox": [993, 1015, 1131, 1015, 1131, 1050, 994, 1050], "text": "reviewed"}, {"boundingBox": [1138, 1015, 1177, 1015, 1177, 1050, 1138, 1050], "text": "by"}, {"boundingBox": [1184, 1015, 1234, 1014, 1235, 1050, 1184, 1050], "text": "the"}, {"boundingBox": [1241, 1014, 1388, 1014, 1388, 1050, 1242, 1050], "text": "Executive"}, {"boundingBox": [1395, 1014, 1493, 1014, 1494, 1050, 1395, 1050], "text": "Safety"}]}, {"boundingBox": [204, 1049, 1449, 1052, 1448, 1088, 203, 1086], "text": "Committee (see Appendix B). The submission reviewed carbohydrate data from all", "words": [{"boundingBox": [207, 1050, 368, 1051, 367, 1087, 206, 1086], "text": "Committee"}, {"boundingBox": [375, 1051, 441, 1052, 441, 1087, 374, 1087], "text": "(see"}, {"boundingBox": [448, 1052, 590, 1053, 590, 1088, 448, 1087], "text": "Appendix"}, {"boundingBox": [597, 1053, 654, 1053, 654, 1088, 597, 1088], "text": "B)."}, {"boundingBox": [670, 1053, 729, 1053, 730, 1088, 670, 1088], "text": "The"}, {"boundingBox": [736, 1053, 902, 1053, 903, 1088, 737, 1088], "text": "submission"}, {"boundingBox": [909, 1053, 1046, 1053, 1047, 1088, 910, 1088], "text": "reviewed"}, {"boundingBox": [1053, 1053, 1254, 1053, 1256, 1088, 1054, 1088], "text": "carbohydrate"}, {"boundingBox": [1264, 1053, 1325, 1053, 1327, 1088, 1265, 1088], "text": "data"}, {"boundingBox": [1332, 1053, 1394, 1053, 1395, 1088, 1334, 1088], "text": "from"}, {"boundingBox": [1408, 1053, 1446, 1052, 1448, 1088, 1410, 1088], "text": "all"}]}, {"boundingBox": [207, 1087, 1405, 1089, 1404, 1126, 206, 1125], "text": "four estrogen/TMG programs and each program consistently showed no clinically", "words": [{"boundingBox": [207, 1089, 265, 1089, 266, 1124, 208, 1124], "text": "four"}, {"boundingBox": [272, 1089, 483, 1090, 484, 1125, 273, 1124], "text": "estrogen/TMG"}, {"boundingBox": [493, 1090, 637, 1091, 637, 1126, 493, 1125], "text": "programs"}, {"boundingBox": [644, 1091, 702, 1091, 702, 1126, 644, 1126], "text": "and"}, {"boundingBox": [709, 1091, 784, 1091, 784, 1126, 709, 1126], "text": "each"}, {"boundingBox": [790, 1091, 909, 1091, 909, 1126, 791, 1126], "text": "program"}, {"boundingBox": [923, 1091, 1102, 1090, 1102, 1126, 923, 1126], "text": "consistently"}, {"boundingBox": [1109, 1090, 1225, 1090, 1225, 1126, 1109, 1126], "text": "showed"}, {"boundingBox": [1232, 1090, 1274, 1090, 1273, 1126, 1232, 1126], "text": "no"}, {"boundingBox": [1281, 1089, 1405, 1089, 1403, 1126, 1280, 1126], "text": "clinically"}]}, {"boundingBox": [200, 1127, 1158, 1128, 1157, 1166, 199, 1165], "text": "meaningful effect of estrogen/TMG on carbohydrate metabolism.", "words": [{"boundingBox": [202, 1129, 369, 1128, 370, 1165, 203, 1164], "text": "meaningful"}, {"boundingBox": [376, 1128, 460, 1128, 460, 1165, 377, 1165], "text": "effect"}, {"boundingBox": [466, 1128, 498, 1128, 498, 1166, 467, 1165], "text": "of"}, {"boundingBox": [505, 1128, 717, 1128, 717, 1166, 505, 1166], "text": "estrogen/TMG"}, {"boundingBox": [728, 1128, 767, 1128, 767, 1166, 728, 1166], "text": "on"}, {"boundingBox": [774, 1128, 970, 1129, 970, 1166, 773, 1166], "text": "carbohydrate"}, {"boundingBox": [977, 1129, 1157, 1130, 1157, 1166, 976, 1166], "text": "metabolism."}]}, {"boundingBox": [201, 1204, 634, 1206, 633, 1241, 200, 1238], "text": "4.8 Hemostatic Measures", "words": [{"boundingBox": [205, 1204, 256, 1205, 257, 1239, 207, 1239], "text": "4.8"}, {"boundingBox": [282, 1205, 465, 1207, 465, 1239, 283, 1239], "text": "Hemostatic"}, {"boundingBox": [472, 1207, 632, 1208, 631, 1240, 472, 1239], "text": "Measures"}]}, {"boundingBox": [200, 1282, 1492, 1284, 1491, 1320, 199, 1318], "text": "The changes in 11 hemostatic measures were assessed. With very few exceptions, all", "words": [{"boundingBox": [207, 1283, 263, 1284, 264, 1319, 208, 1318], "text": "The"}, {"boundingBox": [270, 1284, 399, 1285, 399, 1319, 271, 1319], "text": "changes"}, {"boundingBox": [406, 1285, 436, 1286, 437, 1319, 406, 1319], "text": "in"}, {"boundingBox": [445, 1286, 478, 1286, 479, 1319, 446, 1319], "text": "11"}, {"boundingBox": [485, 1286, 651, 1287, 652, 1319, 486, 1319], "text": "hemostatic"}, {"boundingBox": [658, 1287, 805, 1288, 806, 1319, 659, 1319], "text": "measures"}, {"boundingBox": [812, 1288, 889, 1288, 890, 1319, 813, 1319], "text": "were"}, {"boundingBox": [896, 1288, 1055, 1287, 1056, 1320, 897, 1320], "text": "assessed."}, {"boundingBox": [1062, 1287, 1132, 1287, 1133, 1320, 1063, 1320], "text": "With"}, {"boundingBox": [1139, 1287, 1205, 1287, 1206, 1320, 1140, 1320], "text": "very"}, {"boundingBox": [1212, 1286, 1263, 1286, 1264, 1320, 1213, 1320], "text": "few"}, {"boundingBox": [1275, 1286, 1445, 1284, 1447, 1320, 1276, 1320], "text": "exceptions,"}, {"boundingBox": [1453, 1284, 1490, 1284, 1491, 1321, 1454, 1320], "text": "all"}]}, {"boundingBox": [202, 1320, 1504, 1321, 1503, 1358, 201, 1357], "text": "the doses of Premarin/TMG had similar changes from baseline. Changes from baseline", "words": [{"boundingBox": [205, 1323, 254, 1323, 253, 1355, 204, 1355], "text": "the"}, {"boundingBox": [266, 1323, 353, 1323, 352, 1355, 265, 1355], "text": "doses"}, {"boundingBox": [359, 1323, 391, 1323, 390, 1355, 358, 1355], "text": "of"}, {"boundingBox": [397, 1323, 614, 1323, 613, 1356, 396, 1355], "text": "Premarin/TMG"}, {"boundingBox": [624, 1323, 683, 1323, 682, 1356, 623, 1356], "text": "had"}, {"boundingBox": [689, 1323, 788, 1323, 787, 1356, 688, 1356], "text": "similar"}, {"boundingBox": [795, 1323, 923, 1323, 922, 1356, 793, 1356], "text": "changes"}, {"boundingBox": [930, 1323, 988, 1323, 987, 1357, 928, 1356], "text": "from"}, {"boundingBox": [1005, 1323, 1153, 1323, 1151, 1357, 1004, 1357], "text": "baseline."}, {"boundingBox": [1159, 1323, 1296, 1322, 1294, 1358, 1157, 1357], "text": "Changes"}, {"boundingBox": [1302, 1322, 1361, 1322, 1359, 1358, 1300, 1358], "text": "from"}, {"boundingBox": [1378, 1322, 1504, 1321, 1502, 1359, 1376, 1358], "text": "baseline"}]}, {"boundingBox": [205, 1359, 1489, 1360, 1488, 1397, 204, 1396], "text": "for some measures were in a direction of a decreased predisposition to coagulation but", "words": [{"boundingBox": [205, 1362, 247, 1362, 248, 1395, 205, 1394], "text": "for"}, {"boundingBox": [254, 1362, 336, 1362, 336, 1395, 254, 1395], "text": "some"}, {"boundingBox": [342, 1362, 492, 1362, 493, 1395, 343, 1395], "text": "measures"}, {"boundingBox": [499, 1362, 573, 1362, 573, 1395, 499, 1395], "text": "were"}, {"boundingBox": [579, 1362, 609, 1362, 609, 1395, 579, 1395], "text": "in"}, {"boundingBox": [617, 1362, 638, 1362, 638, 1395, 617, 1395], "text": "a"}, {"boundingBox": [647, 1362, 772, 1362, 771, 1396, 647, 1395], "text": "direction"}, {"boundingBox": [780, 1362, 812, 1362, 811, 1396, 780, 1396], "text": "of"}, {"boundingBox": [818, 1362, 839, 1362, 839, 1396, 818, 1396], "text": "a"}, {"boundingBox": [848, 1362, 1002, 1362, 1002, 1396, 847, 1396], "text": "decreased"}, {"boundingBox": [1009, 1362, 1218, 1361, 1217, 1397, 1008, 1396], "text": "predisposition"}, {"boundingBox": [1224, 1361, 1256, 1361, 1255, 1397, 1223, 1397], "text": "to"}, {"boundingBox": [1262, 1361, 1436, 1360, 1434, 1398, 1261, 1397], "text": "coagulation"}, {"boundingBox": [1442, 1360, 1489, 1360, 1487, 1398, 1441, 1398], "text": "but"}]}, {"boundingBox": [199, 1400, 1361, 1401, 1360, 1435, 198, 1433], "text": "were balanced by changes for other measures in the direction of an increased", "words": [{"boundingBox": [203, 1400, 276, 1400, 278, 1433, 204, 1432], "text": "were"}, {"boundingBox": [283, 1400, 424, 1401, 425, 1433, 284, 1433], "text": "balanced"}, {"boundingBox": [430, 1401, 468, 1401, 469, 1434, 431, 1433], "text": "by"}, {"boundingBox": [474, 1401, 602, 1401, 603, 1434, 475, 1434], "text": "changes"}, {"boundingBox": [608, 1401, 653, 1402, 653, 1434, 609, 1434], "text": "for"}, {"boundingBox": [659, 1402, 737, 1402, 737, 1434, 660, 1434], "text": "other"}, {"boundingBox": [743, 1402, 892, 1402, 893, 1435, 744, 1434], "text": "measures"}, {"boundingBox": [898, 1402, 926, 1402, 926, 1435, 899, 1435], "text": "in"}, {"boundingBox": [934, 1402, 983, 1402, 983, 1435, 935, 1435], "text": "the"}, {"boundingBox": [993, 1402, 1119, 1402, 1119, 1435, 993, 1435], "text": "direction"}, {"boundingBox": [1125, 1402, 1159, 1402, 1159, 1435, 1125, 1435], "text": "of"}, {"boundingBox": [1165, 1402, 1203, 1402, 1203, 1434, 1165, 1435], "text": "an"}, {"boundingBox": [1210, 1402, 1359, 1402, 1358, 1434, 1209, 1434], "text": "increased"}]}, {"boundingBox": [203, 1438, 1274, 1437, 1275, 1472, 204, 1473], "text": "predisposition to coagulation. Similar changes have been seen with other", "words": [{"boundingBox": [206, 1439, 413, 1439, 410, 1474, 204, 1474], "text": "predisposition"}, {"boundingBox": [420, 1439, 452, 1439, 449, 1474, 417, 1474], "text": "to"}, {"boundingBox": [458, 1439, 642, 1438, 640, 1474, 456, 1474], "text": "coagulation."}, {"boundingBox": [649, 1438, 751, 1438, 749, 1474, 647, 1474], "text": "Similar"}, {"boundingBox": [758, 1438, 885, 1439, 883, 1473, 756, 1473], "text": "changes"}, {"boundingBox": [892, 1439, 967, 1439, 965, 1473, 890, 1473], "text": "have"}, {"boundingBox": [974, 1439, 1053, 1439, 1051, 1472, 972, 1473], "text": "been"}, {"boundingBox": [1060, 1439, 1133, 1439, 1131, 1472, 1058, 1472], "text": "seen"}, {"boundingBox": [1139, 1439, 1203, 1439, 1201, 1472, 1138, 1472], "text": "with"}, {"boundingBox": [1210, 1439, 1276, 1439, 1274, 1471, 1208, 1472], "text": "other", "confidence": "Low"}]}, {"boundingBox": [205, 1477, 630, 1476, 630, 1513, 206, 1513], "text": "estrogen/progestin products.", "words": [{"boundingBox": [206, 1477, 483, 1477, 481, 1513, 206, 1514], "text": "estrogen/progestin"}, {"boundingBox": [490, 1477, 629, 1478, 627, 1513, 488, 1513], "text": "products."}]}, {"boundingBox": [201, 2073, 405, 2071, 405, 2107, 202, 2110], "text": "Confidential", "words": [{"boundingBox": [207, 2075, 405, 2071, 406, 2109, 208, 2111], "text": "Confidential"}]}, {"boundingBox": [807, 2073, 930, 2072, 931, 2105, 808, 2106], "text": "16 of 42", "words": [{"boundingBox": [808, 2075, 843, 2074, 844, 2105, 810, 2106], "text": "16"}, {"boundingBox": [851, 2073, 890, 2073, 890, 2105, 852, 2105], "text": "of"}, {"boundingBox": [898, 2073, 929, 2073, 929, 2106, 898, 2105], "text": "42"}]}, {"boundingBox": [21, 2200, 490, 2205, 489, 2234, 20, 2230], "text": "Confidential Pursuant to Confidentiality", "words": [{"boundingBox": [21, 2201, 165, 2203, 166, 2232, 22, 2230], "text": "Confidential"}, {"boundingBox": [171, 2203, 283, 2204, 283, 2233, 171, 2232], "text": "Pursuant"}, {"boundingBox": [289, 2204, 315, 2204, 316, 2233, 289, 2233], "text": "to"}, {"boundingBox": [321, 2204, 489, 2205, 490, 2234, 321, 2233], "text": "Confidentiality"}]}, {"boundingBox": [1429, 2208, 1677, 2208, 1676, 2236, 1428, 2235], "text": "KERZC001-000289", "words": [{"boundingBox": [1435, 2208, 1677, 2209, 1676, 2236, 1435, 2236], "text": "KERZC001-000289"}]}, {"boundingBox": [20, 2234, 92, 2235, 92, 2262, 19, 2261], "text": "Order", "words": [{"boundingBox": [22, 2237, 91, 2236, 92, 2262, 23, 2261], "text": "Order"}]}, {"boundingBox": [377, 2242, 1339, 2239, 1340, 2279, 378, 2281], "text": "Source: https://www.industrydocuments.ucsf.edu/docs/yrvw0217", "words": [{"boundingBox": [381, 2246, 493, 2246, 493, 2279, 380, 2278], "text": "Source:"}, {"boundingBox": [499, 2246, 1334, 2240, 1335, 2279, 499, 2279], "text": "https://www.industrydocuments.ucsf.edu/docs/yrvw0217"}]}]}]}